HONGQI EH7 and EHS7 Have Become “Explosive Hit Vehicles” at the Paris Motor Show 2024
On October 14th, HONGQI made its debut at the Paris Motor Show 2024 with its new energy vehicles, the EH7 and EHS7, and announced the opening of orders in Europe. These two new models garnered the attention of global consumers with their excellent performance and reasonable pricing. HONGQI added a splash of vibrant Chinese red to the Paris Motor Show 2024.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241016885021/en/
HONGQI EH7 and EHS7 Have Become “Explosive Hit Vehicles” at the Paris Motor Show 2024 (Photo: Business Wire)
At the Launch, Mr. Liu Changqing, the Vice President of HONGQI Brand Operation Committee FAW, delivered a brand presentation, showcasing the world the unique charm and profound heritage of the HONGQI brand. Mr. Liu Changqing introduced two new vehicles EH7 and EHS7, which garnered significant attention due to their excellent design and advanced technology. He also announced the prices of these two vehicles: EH7 is priced starting at €49,999, while the EHS7 is priced starting at €53,999, providing consumers with a cost-effective option.
On the event day, Joyce Jonathan, a famous French singer, made a stunning appearance with elegance and she was honored to be the first user of the HONGQI EHS7. HONGQI also officially announced the launch of a meaningful co-branding project with the internationally renowned fabric manufacturer SCABAL, which is also a joint tribute to the spirit of quality and innovation.
This unveiling and opening ordering of HONGQI EH7 and EHS7 at the Paris Motor Show 2024 have made them the center of attention at the show due to their excellent product quality, cost-effective price, and sincere service policy. This launch shows the world the strong strength of HONGQI in the field of new energy, and lays a solid foundation for HONGQI to become the “World’s New Luxury Automotive Brand.”
The development strategy of HONGQI in the European market is clear, and it will actively lay out the new energy channel network, strengthen communication and cooperation with European partners, and enhance brand awareness and influence. Within the next five years, HONGQI will launch another 10 new models to meet the needs of European and global consumers for high-quality, intelligent, and eco-friendly vehicles.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241016885021/en/
Contacts
China FAW Group Import & Export Co., Ltd
Lin Ding
https://www.hongqi-auto.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.hongqi-aut
o.com&esheet=54136947&newsitemid=20241016885021&lan=en-US&anchor=https%3A%2F%2Fw
ww.hongqi-auto.com&index=6&md5=dbea76d1e47f952e9ac781b62452cf59
dinglin7@faw.com.cn
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per
Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West17.12.2025 04:00:00 CET | Press Release
The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today published its annual Global Power City Index (GPCI) 2025, a report evaluating the urban competitiveness of 48 major cities worldwide. The report also includes the GPCI–Financial Centers index, an assessment of cities as international financial centers, and the new GPCI–Startup Ecosystems index, which assesses the competitiveness of startup environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216187692/en/ 48 Major Cities Evaluated in Mori Memorial Foundation’s GPCI-2025 Report This year’s report highlights the remarkable rise of East Asian cities and the stagnation of several Western cities, showing how global challenges, such as geopolitical tensions and regional disparities in inflation, are greatly impacting the performance of major cities worldwide. The r
GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners17.12.2025 03:00:00 CET | Press Release
GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully competitive international tender process governed by the World Bank’s procurement regulations. SIHREN is the largest healthcare infrastructure investment in Indonesia’s history and among the largest multilateral health projects globally. SIHREN aims to modernize the national referral system and expand access to diagnostics and treatment across the archipelago, with a focus on non-communicable diseases (NCD) management, maternal health, and pandemic resilience. By mode
IDWS 2025 Concludes with Focus on Global Knowledge Exchange, Financial Opportunities, and Scalable Water Solutions16.12.2025 20:03:00 CET | Press Release
The 4th Innovation Driven Water Sustainability Conference (IDWS) 2025 concluded on Wednesday in Jeddah, confirming its status as one of the world’s most influential platforms for shaping the future of water innovation, sustainability, and security. Gathering senior global policymakers and international industry leaders, this year’s edition has advanced critical dialogue on safeguarding the planet’s most vital resource, with Saudi Arabia at the forefront. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216483490/en/ Investors, innovators, and global institutions gather in Saudi to outline how capital, collaboration, and governance can accelerate long term water sustainability (Photo: AETOSWire) Among the most consequential engagements were a series of meetings that brought together discussions powered by SWA, centred on shared challenges, knowledge exchange, and exploring opportunities within the global water ecosystem. Att
OAG Appoints ex-Skyscanner Executive Filip Filipov as New Chief Executive Officer16.12.2025 17:00:00 CET | Press Release
OAG announces today the appointment of Filip Filipov, ex-Skyscanner executive, as new Chief Executive Officer. Filip Filipov currently serves as the company’s Chief Operating Officer and takes over from Phil Callow who has chosen to step down having completed thirteen transformational years at the helm of OAG to pursue his many other interests. Since joining in 2024, Filipovhas played a leading role in the company’s ambitious next phase of growth and ongoing acceleration. He will now lead OAG into a new era defined by advanced data products and AI-driven intelligence. Before joining OAG, Filipov held senior roles in travel technology and big-data consulting, including on Skyscanner’s executive team. Filip Filipov said: “It’s a privilege to step into this role and lead a company with such a strong heritage and reputation. I’m excited for what’s ahead and committed to serving our customers with the reliability, service, and innovation they depend on.” Chairman of OAG, Gehan Talwatte, com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom